Author: Hannah Gantt, LPCC
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that plays a pivotal role in cellular metabolism and is found in all living cells. As a critical component of the metabolic processes, NAD+ is involved in the conversion of food into energy, repairing damaged DNA, and regulating cellular signaling and gene expression. The significance of NAD+ extends beyond mere energy production; it is essential for maintaining mitochondrial health, which is crucial for preventing aging-related diseases, especially neurodegenerative disorders.
One of the most notable aspects of NAD+ is its decline with age, which is associated with various age-related diseases such as diabetes, heart disease, neurodegenerative conditions, and even certain cancers. This decrease in NAD+ levels is also linked to reduced mitochondrial function, affecting the body's energy production and cellular health. Factors such as stress, excessive alcohol consumption, and poor diet can accelerate the depletion of NAD+.
Emerging research indicates that NAD+ supplementation could offer several health benefits, including enhanced muscle function, improved mitochondrial health, delayed aging, and possibly extending lifespan. Animal studies have shown promising results, with NAD+ supplementation improving aspects of age-related decline. However, human studies are still in the early stages, and more research is needed to confirm these potential benefits.
NAD+ operates by supporting enzymes involved in metabolic processes. For instance, it assists in the generation of ATP, the energy currency of the cell, through its role in the electron transport chain. Furthermore, NAD+ is involved in the activation of sirtuins, a family of proteins that regulate cellular health and longevity, and PARPs (poly ADP-ribose polymerases), which are crucial for DNA repair and maintaining genomic stability.
Several strategies can help increase NAD+ levels in the body. Dietary intake of foods rich in niacin (vitamin B3) and tryptophan can boost NAD+ production. Additionally, precursors to NAD+ such as NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are being studied for their potential to elevate NAD+ levels and mitigate age-related decline. These precursors can be taken as supplements, although their effectiveness and the optimal mode of delivery (oral, injection, or IV) are still under investigation.
While preliminary data on NAD+ supplementation is promising, comprehensive safety studies, especially in humans, are lacking. The potential for NAD+ to improve DNA repair and stimulate angiogenesis raises questions about its effects on cancer cells, although animal studies have not shown an increased risk of cancer. As with any supplement, it is crucial to consult with healthcare providers before starting NAD+ supplementation.
NAD+ plays a vital role in cellular metabolism, energy production, and the regulation of longevity genes. While the decline of NAD+ is linked to aging and various diseases, supplementation offers a potential avenue for mitigating these effects. However, more research, particularly in human subjects, is needed to fully understand the benefits, optimal dosages, and long-term safety of NAD+ supplementation. As the field of aging and longevity continues to evolve, NAD+ remains a key molecule of interest for its potential to influence healthspan and lifespan.
Verdin, E. (2015). NAD+ in aging, metabolism, and neurodegeneration. Science, 350(6265), 1208-1213.
Rajman, L., Chwalek, K., & Sinclair, D.A. (2018). Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metabolism, 27(3), 529-547.
Yoshino, J., Baur, J.A., & Imai, S.I. (2018). NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metabolism, 27(3), 513-528.
Camacho-Pereira, J., Tarragó, M.G., Chini, C.C.S., Nin, V., Escande, C., Warner, G.M., Puranik, A.S., Schoon, R.A., Reid, J.M., Galina, A., & Chini, E.N. (2016). CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism, 23(6), 1127-1139.
